{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:41:21Z","timestamp":1782517281329,"version":"3.54.5"},"reference-count":12,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ThoracResPract"],"DOI":"10.4274\/thoracrespract.2025.s012","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:56:36Z","timestamp":1764590196000},"source":"Crossref","is-referenced-by-count":2,"title":["Nanoparticle-Based Therapeutic Strategies in Respiratory Diseases: Current Approaches and Future Perspectives"],"prefix":"10.4274","author":[{"given":"Ozge","family":"Cinar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilgin Kimiz","family":"Gebologlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suphi S.","family":"Oncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"ref0","unstructured":"1. GBD 2019 Chronic Respiratory Diseases Collaborators. Global burden of chronic respirato-ry diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023;59:101936."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1059343","DOI":"10.3389\/fphar.2023.1059343","article-title":"Recent advances in na-noparticle applications in respiratory disorders: a review","volume":"14","author":"Taghavizadeh Yazdi","year":"2023","unstructured":"2. Taghavizadeh Yazdi ME, Qayoomian M, Beigoli S, Boskabady MH. Recent advances in na-noparticle applications in respiratory disorders: a review. Front Pharma-col. 2023;14:1059343.","journal-title":"Front Pharma-col"},{"issue":"7","key":"ref2","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s12274-020-3180-3","article-title":"Recent applications and strategies in nanotechnolo-gy for lung diseases","volume":"14","author":"Zhong","year":"2021","unstructured":"3. Zhong W, Zhang X, Zeng Y, Lin D, Wu J. Recent applications and strategies in nanotechnolo-gy for lung diseases. Nano Res. 2021;14(7):2067-2089.","journal-title":"Nano Res"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Georgakopoulou VE, Papalexis P, Trakas N. Nanotechnology-based approaches for targeted drug delivery for the treatment of respiratory tract infections. J Biol Meth-ods. 2024;11(4):e99010032.","DOI":"10.14440\/jbm.2024.0065"},{"issue":"1","key":"ref4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/0970-2113.92361","article-title":"Pulmonary drug delivery strategies: a concise, systematic review","volume":"29","author":"JS","year":"2012","unstructured":"5. Patil JS, Sarasija S. Pulmonary drug delivery strategies: a concise, systematic review. Lung India. 2012;29(1):44-49.","journal-title":"Lung India"},{"issue":"22","key":"ref5","doi-asserted-by":"publisher","first-page":"2112258","DOI":"10.1002\/adfm.202112258","article-title":"Nanomedicines targeting respiratory injuries for pulmonary dis-ease management","volume":"32","author":"Liu","year":"2022","unstructured":"6. Liu D, Long M, Gao L, et al. Nanomedicines targeting respiratory injuries for pulmonary dis-ease management. Adv Funct Mater. 2022;32(22):2112258.","journal-title":"Adv Funct Mater"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1080\/10717544.2022.2089294","article-title":"Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives","volume":"29","author":"Chen","year":"2022","unstructured":"7. Chen M, Shou Z, Jin X, Chen Y. Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives. Drug Deliv. 2022;29(1):2442-2458.","journal-title":"Drug Deliv"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.actbio.2022.06.024","article-title":"ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment","volume":"148","author":"Muhammad","year":"2022","unstructured":"8. Muhammad W, Zhu J, Zhai Z, et al. ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment. Acta Bi-omater. 2022;148:258-270.","journal-title":"Acta Bi-omater"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1021\/acsnano.2c12165","article-title":"Inhalable GSH-triggered nanoparticles to treat commensal bac-terial infection in in situ lung tumors","volume":"17","author":"Ma","year":"2023","unstructured":"9. Ma Z, Wang H, Shi Z, et al. Inhalable GSH-triggered nanoparticles to treat commensal bac-terial infection in in situ lung tumors. ACS Nano. 2023;17(6):5740-5756.","journal-title":"ACS Nano"},{"issue":"4","key":"ref9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1080\/08982104.2018.1531022","article-title":"Lung delivery of nanoliposomal salbutamol sulfate dry powder inhalation for facilitated asthma therapy","volume":"29","author":"Honmane","year":"2019","unstructured":"10. Honmane S, Hajare A, More H, Osmani RAM, Salunkhe S. Lung delivery of nanoliposomal salbutamol sulfate dry powder inhalation for facilitated asthma therapy. J Liposome Res. 2019;29(4):332-342.","journal-title":"J Liposome Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"101128","DOI":"10.1016\/j.jddst.2019.101128","article-title":"Development and characterization of PLA nanoparticles for pulmonary drug delivery: co-encapsulation of theophylline and budesonide, a hydrophilic and lipophilic drug","volume":"53","author":"Buhecha","year":"2019","unstructured":"11. Buhecha MD, Lansley AB, Somavarapu S, Pannala AS. Development and characterization of PLA nanoparticles for pulmonary drug delivery: co-encapsulation of theophylline and budesonide, a hydrophilic and lipophilic drug. J Drug Deliv Sci Technol. 2019;53:101128.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"4","key":"ref11","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s13346-021-01003-7","article-title":"Mannose-conjugated chitosan nanoparticles for delivery of rifampicin to osteoarticular tuberculosis","volume":"11","author":"Prabhu","year":"2021","unstructured":"12. Prabhu P, Fernandes T, Chaubey P, et al. Mannose-conjugated chitosan nanoparticles for delivery of rifampicin to osteoarticular tuberculosis. Drug Deliv Transl Res. 2021;11(4):1509-1519.","journal-title":"Drug Deliv Transl Res"}],"container-title":["Thoracic Research and Practice"],"original-title":[],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T07:23:14Z","timestamp":1764919394000},"score":1,"resource":{"primary":{"URL":"https:\/\/thoracrespract.org\/articles\/nanoparticle-based-therapeutic-strategies-in-respiratory-diseases-current-approaches-and-future-perspectives\/doi\/ThoracResPract.2025.s012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":12,"URL":"https:\/\/doi.org\/10.4274\/thoracrespract.2025.s012","relation":{},"ISSN":["2979-9139"],"issn-type":[{"value":"2979-9139","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}